Literature DB >> 3771754

Passive hemagglutination test for antibody to hepatitis B core antigen.

B Petchclai, K Khupulsup, C Wasi, N Bhamarapravati.   

Abstract

Available tests for antibody to hepatitis B core antigen (anti-HBc) are complicated. A passive hemagglutination assay for anti-HBc was developed by sensitizing sheep erythrocytes with hepatitis B core antigen synthesized by a recombinant DNA technique. It was compared with a commercial passive hemagglutination assay and an enzyme-linked immunosorbent assay for anti-HBc and showed good agreement with both. It is rapid, simple, and sensitive.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3771754      PMCID： PMC268989          DOI： 10.1128/jcm.24.4.642-643.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

2.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

3.  Use of the hepatitis B core antigen produced in Escherichia coli in an assay for anti-HBc.

Authors:  J F Peutherer; P MacKay; R Ross; S Stahl; K Murray
Journal:  Med Lab Sci       Date:  1981-10

4.  Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis.

Authors:  S Stahl; P MacKay; M Magazin; S A Bruce; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted diseases.

Authors:  B J Cohen; P A Litton; P P Mortimer; P Simmons
Journal:  J Hyg (Lond)       Date:  1984-10

6.  Application of a screening test for antibody the hepatitis B core antigen.

Authors:  B J Cohen; Y E Cossart
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

7.  The value of screening blood donors for antibody to hepatitis B core antigen.

Authors:  A C Archer; B J Cohen; P P Mortimer
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

8.  Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

Authors:  A G Mulley; M D Silverstein; J L Dienstag
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

9.  Comparison of hepatitis B core antigens derived from human liver or synthesized in Escherichia coli and evaluation of their use in diagnostic assays for anti-HBc IgM.

Authors:  M Roggendorf; F Deinhardt; R Zachoval; K von der Helm
Journal:  J Virol Methods       Date:  1983-02       Impact factor: 2.014

10.  Antibody to hepatitis B core antigen in blood donors with a history of hepatitis.

Authors:  E Tabor; J H Hoofnagle; L F Barker; G Pineda-Tamondong; N Nath; L A Smallwood; R J Gerety
Journal:  Transfusion       Date:  1981 May-Jun       Impact factor: 3.157
  10 in total
  1 in total

1.  Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis.

Authors:  M B Vasudevachari; K W Uffelman; T C Mast; R L Dewar; V Natarajan; H C Lane; N P Salzman
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.